Corrigendum to "Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure"
Tumori. 2023 Jul 4:3008916231186888. doi: 10.1177/03008916231186888. Online ahead of print.NO ABSTRACTPMID:37401422 | DOI:10.1177/03008916231186888 (Source: Tumori)
Source: Tumori - July 4, 2023 Category: Cancer & Oncology Source Type: research
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib
Tumori. 2023 Jun 2:3008916231176586. doi: 10.1177/03008916231176586. Online ahead of print.ABSTRACTMultiple myeloma is a hematological cancer characterized by relapse after treatment and poor prognosis. Ixazomib, a second-generation protease inhibitor, is one of the most recently available treatments for relapsed or refractory multiple myeloma, while it has also shown good potential as antitumoral agent in preclinical solid tumor models such as breast cancer cell lines. Here we report the case of a 68-year-old female with multiple myeloma and an incidental cT1b (9 mm) hormone receptor positive breast cancer lesion that sho...
Source: Tumori - June 2, 2023 Category: Cancer & Oncology Authors: Martina Dameri Alessandro Garlaschi Paola Cuccarolo Andrea Ceccardi Mario Stabile Irene Valente Licia Gristina Massimo Calabrese Alberto Ballestrero Alberto Tagliafico Gabriele Zoppoli Source Type: research
